Business · 1 sources covering this

Biogen is set for big gains on slate of trial data releases, JPMorgan says

Biogen will release data from clinical trials for a few of its investigational treatments over the next few months, which should boost its shares, per JPMorgan.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

CNBCLean R·2h ago
Biogen is set for big gains on slate of trial data releases, JPMorgan says
Biogen will release data from clinical trials for a few of its investigational treatments over the next few months, which should boost its shares, per JPMorgan.
Read at CNBC →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/1e0689cb0a2eb27474a89496e10d23d4f910b2b2"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Biogen is set for big gains on slate of trial data releases, JPMorgan says"></iframe>

Biogen is set for big gains on slate of trial data releases, JPMorgan says

How 1 sources are covering this

Biogen is set for big gains on slate of trial data releases, JPMorgan says

More from Business

Elon Musk, Delta Airlines and a Feud Over In-Flight Wi-Fi

Stock futures are little changed to start the week: Live updates

Rep. Ilhan Omar's home raided by DHS in fraud probe of immigration paperwork: Report

Strikes Put Saudi Arabia’s Economy Under Pressure

Reader

Trust & legal

Across the network